DUBLIN 18, Ireland (AP) — Icon PLC (ICLR) on Wednesday reported fourth-quarter net income of $260 million. The Dublin 18, Ireland-based company said it had profit of $3.16 per share. Earnings, ...

For more information, submit a form at ICON plc Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030. According ...

If you purchased ICON ordinary shares during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO ...

Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ICON PLC ("ICON" or "the Company") (NASDAQ:ICLR ...

Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024. ICON is a ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will release financial results for the fourth ...

DUBLIN, January 29, 2025--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will release financial ...

notifies investors that a class action lawsuit has been filed against ICON PLC (“ICON” or “the Company”) (NASDAQ: ICLR) and certain of its officers. Class Definition This lawsuit seeks to ...

Icon plc has launched a new buyback program to repurchase up to $750 million of its shares. The total value of the authorized share repurchase is now up to $1 billion, the healthcare intelligence and ...

In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against other AI news and ratings too important to miss. Artificial intelligence is rapidly ...

DUBLIN, January 30, 2025--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of ...